Patel et al. hypothesized that the region between c.7914 and 3’ of the BRCA2 gene is a cluster region associated with an increased risk of developing prostate cancer [31]; however, only one of the mutations found in our patients falls in that region. The gene discussed is BRCA2; the disease is Familial prostate cancer.